Every filing period on record, as reported. One column per filed period — a period with no column is a period with no filing, not a zero.
Basis · Amendments and terminations supersede the original report for the same registrant, client and period, so a revised quarter is counted once at its latest filed value. Registration-only filings carry no activity money and are excluded from these totals.
Who lobbies for them
Every outside firm that has filed on this client's behalf, by fees reported.
This record groups every filed spelling of the client's name into one entity, so "MERCK & CO., INC." and "MERCK & CO INC" read as the same company. The grouping is the client's normalized name — organizations that file under genuinely different names appear separately. Handle: endo-pharmaceuticals-inc.
Reading this · LD-2 reports a hired firm's fee and a registrant's reported expenses on separate lines and never both on one filing, so the two lists above are different quantities and are ranked separately rather than against each other. Firm names link to their own record as the firms chapter lands.
CPT
38 filings
$1.4M on those filings
Pharmacy
PHA
28 filings
$890K on those filings
Torts
TOR
5 filings
$140K on those filings
Government Issues
GOV
4 filings
$120K on those filings
Note · A filing names one to several issue areas and reports a single dollar figure for the period, so the same money appears beside every issue that filing declares. The dollar column is therefore spend on filings that named this issue — it is not a split of the total, and these figures sum above it. Filing counts do not double-count.
114th Congress
Innovation Act
13 filingsthrough 2016
S. 1137114th CongressPATENT Act11 filingsthrough 2016
S. 483114th CongressEnsuring Patient Access and Effective Drug Enforcement Act of 201611 filingsthrough 2016
H.R. 486113th CongressStop Tampering of Prescription Pills Act of 201311 filingsthrough 2014
H.R. 1919113th CongressSafeguarding America's Pharmaceuticals Act of 201310 filingsthrough 2014
H.R. 5748114th CongressTo establish the Adams Memorial Commission to carry out the provisions of Public Law 107-62, and for other purposes.9 filingsthrough 2016
H.R. 523113th CongressProtect Medical Innovation Act of 20139 filingsthrough 2014
S. 232113th CongressMedical Device Access and Innovation Protection Act9 filingsthrough 2014
H.R. 2632112th CongressLife Sciences Jobs and Investment Act of 20118 filingsthrough 2012
H.Res. 106114th CongressSupporting quality of life for prostate cancer patients.6 filingsthrough 2015
H.R. 3204113th CongressDrug Quality and Security Act6 filingsthrough 2014
S. 319112th CongressPharmaceutical Market Access and Drug Safety Act of 20116 filingsthrough 2012
How these are found · Bill references are extracted from the free-text activity description each filing writes, then matched to the Congress in session that filing year. A reference we can't match to a bill on file is still shown, unlinked — we cite what the filing said rather than guess at what it meant. Naming a bill is not a position on it: LD-2 records that a client lobbied on the bill, never which side.
Covered position:
11 filingsthrough 2013
Chris JonesFerguson Strategies, LLCCovered position: Chief of Staff/Rep. Mike FergusonDeputy Chief of Staff/Rep. David McIntoshCommunications Dir./House Govt. Reform and Oversight SubcmtePress Secretary/Rep. John Myers9 filingsthrough 2015
Adam HigginsFerguson Strategies, LLC9 filingsthrough 2015
Bart StupakVenable LLPCovered position: U.S. Representative - 1993-20116 filingsthrough 2013
W.J. TauzinTauzin Strategic NetworksCovered position: Member of Congress (LA-3)6 filingsthrough 2013
EARL RAY BEEMAN iiiVenable LLPCovered position: Legis. Cnsl, Jt. Comm. on Taxation2 filingsthrough 2010
Ellen RikerHolland & Knight LLP1 filingthrough 2010
